These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26559153)

  • 1. miR-539 induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin-dependent kinase 4.
    Lv LY; Wang YZ; Zhang Q; Zang HR; Wang XJ
    Cell Biochem Funct; 2015 Dec; 33(8):534-40. PubMed ID: 26559153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
    Li YQ; Ren XY; He QM; Xu YF; Tang XR; Sun Y; Zeng MS; Kang TB; Liu N; Ma J
    Cell Death Dis; 2015 Jan; 6(1):e1618. PubMed ID: 25611392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.
    Xu YF; Mao YP; Li YQ; Ren XY; He QM; Tang XR; Sun Y; Liu N; Ma J
    Cancer Lett; 2015 Jul; 363(2):146-55. PubMed ID: 25892549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma.
    Liu Z; Cheng C; Luo X; Xia Q; Zhang Y; Long X; Jiang Q; Fang W
    BMC Cancer; 2016 Mar; 16():238. PubMed ID: 26993269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-16 induction after CDK4 knockdown is mediated by c-Myc suppression and inhibits cell growth as well as sensitizes nasopharyngeal carcinoma cells to chemotherapy.
    Jiang Q; Zhang Y; Zhao M; Li Q; Chen R; Long X; Fang W; Liu Z
    Tumour Biol; 2016 Feb; 37(2):2425-33. PubMed ID: 26383521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer.
    Li D; Li DQ; Liu D; Tang XJ
    Cell Oncol (Dordr); 2016 Apr; 39(2):139-47. PubMed ID: 26744345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.
    Li YQ; Lu JH; Bao XM; Wang XF; Wu JH; Hong WQ
    J Exp Clin Cancer Res; 2015 Oct; 34():130. PubMed ID: 26503504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
    Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.
    Liu N; Tang LL; Sun Y; Cui RX; Wang HY; Huang BJ; He QM; Jiang W; Ma J
    Cancer Lett; 2013 Feb; 329(2):181-8. PubMed ID: 23142282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells.
    Wu J; Yin L; Jiang N; Guo WJ; Gu JJ; Chen M; Xia YY; Wu JZ; Chen D; Wu JF; Wang DJ; Zong D; Zhang N; Ding K; Huang T; He X
    Exp Cell Res; 2015 Nov; 338(2):232-8. PubMed ID: 26297956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.
    Chen C; Lu Z; Yang J; Hao W; Qin Y; Wang H; Xie C; Xie R
    Cancer Med; 2016 Dec; 5(12):3489-3499. PubMed ID: 27774777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma.
    Peng XH; Huang HR; Lu J; Liu X; Zhao FP; Zhang B; Lin SX; Wang L; Chen HH; Xu X; Wang F; Li XP
    Mol Cancer; 2014 Aug; 13():186. PubMed ID: 25098939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
    Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
    J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
    Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
    Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.
    Yi C; Wang Q; Wang L; Huang Y; Li L; Liu L; Zhou X; Xie G; Kang T; Wang H; Zeng M; Ma J; Zeng Y; Yun JP
    Oncogene; 2012 Oct; 31(41):4421-33. PubMed ID: 22249270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.
    Zhang Y; Zhang W
    Cancer Biomark; 2020; 28(4):511-521. PubMed ID: 32568181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.
    Yang W; Lan X; Li D; Li T; Lu S
    BMC Cancer; 2015 Jun; 15():461. PubMed ID: 26055874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
    Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
    J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
    Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
    Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z; Zhao Y
    BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.